4 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Cardiac Disease: new trials by email Literature Review of Cardiac Disease trials Research Report on Cardiac Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE Placebo, Ravulizumab - Chronic Kidney Disease, CKD | Phase 3 | Terminated | Alexion Pharmaceuticals, Inc. | 555 | 2023-04-06 | 2026-10-29 |
| Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study) Atenolol, Telmisartan - Cardiac Disease | Phase 3 | Terminated | Hamilton Health Sciences Corporation | 85 | 2011-06-01 | 2019-09-18 |
| Moxonidine in Patients Undergoing Vascular Surgery moxonidine - Cardiac Disease, Vascular Surgery | Phase 3 | Terminated | University Hospital, Basel, Switzerland | 141 | 2002-11-01 | 2009-11-10 |
| Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System GE Attenuation Corrected Hawkeye Camera - Cardiac Disease | Phase 2 / Phase 3 | Terminated | Mayo Clinic | 608 | 2001-07-01 | 2015-04-23 |
Heart Diseases (4) · Bicuspid Aortic Valve Disease (1) · Chest Pain (1) · Myocardial Infarction (1) · Renal Insufficiency, Chronic (1)
Cardiovascular Diseases (4) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Aortic Valve Disease (1) · Cardiovascular Abnormalities (1) · Chronic Disease (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Defects, Congenital (1) · Heart Valve Diseases (1) · Infarction (1) · Ischemia (1)
Atenolol (1) · Telmisartan (1) · moxonidine (1) · ravulizumab (1)
Alexion Pharmaceuticals, Inc. (1) · Hamilton Health Sciences Corporation (1) · Mayo Clinic (1) · University Hospital, Basel, Switzerland (1)
Canada (2) · United States (2) · Argentina (1) · Australia (1) · Brazil (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1)
Judith Therrien, MD (1) · Miodrag Filipovic, PD Dr. (1) · Todd D Miller, MD (1) · Tolga Baykal, MD, PhD (1)